Aferetica has been selected for the Premio Paolo Mascagni 2026, recognising entrepreneurial excellence in the territory — together with Confindustria Emilia Area Centro and Il Resto del Carlino.
On this occasion, journalist Maria Silvia Cabri publishes an in-depth portrait of Aferetica and CEO Mauro Atti in Quotidiano Nazionale — tracing the company’s origins, built on direct dialogue with the clinical community including Professor Remuzzi of the Mario Negri Institute, through to today’s challenges and tomorrow’s horizons.
At the centre: what it means to act as a catalyst between research and industry in one of Europe’s leading biomedical districts, and how an interdisciplinary team translates clinical needs into concrete therapeutic solutions. Aferetica’s organ perfusion and transport systems are today adopted by leading international transplant centres. The next frontier is already in sight: xenotransplantation, and the perfusion technologies that will make it possible.
Read the full article (in Italian): https://bit.ly/4fOJsJ2
